Merck KGaA (LON:0O14)

Market Cap	43.51B
Revenue (ttm)	17.50B
Net Income (ttm)	2.30B
Shares Out	n/a
EPS (ttm)	5.28
PE Ratio	18.94
Forward PE	n/a
Dividend	1.88 (1.63%)
Ex-Dividend Date	Apr 28, 2025

Volume	42,294
Average Volume	178,805
Open	113.40
Previous Close	112.45
Day's Range	112.35 - 115.45
52-Week Range	112.80 - 146.53
Beta	0.70
RSI	37.67
Earnings Date	May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,020
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR